Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LHBETATAG retinoblastoma tumors
Samuel K Houston1, Yolanda Piña1, Timothy G Murray1, Hinda Boutrid1, Colleen Cebulla2, Amy C Schefler1, Wei Shi1, Magda Celdran1, William Feuer1, Jaime Merchan3, Ted J Lampidis41Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Mi...
Guardado en:
Autores principales: | Samuel K Houston, Yolanda Piña, Timothy G Murray, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/53070346f806424da994348219397f39 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LHBETATAG retinal tumors
por: Piña Y, et al.
Publicado: (2012) -
Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LHBETATAG retinal tumors
por: Y Piña, et al.
Publicado: (2011) -
Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma
por: Lejla Mutapcic Vajzovic, et al.
Publicado: (2011) -
Retinoblastoma
por: Marchevsky,Silvia, et al.
Publicado: (1979) -
Prevalence of refractive errors in children with retinoblastoma
por: Villegas VM, et al.
Publicado: (2019)